Evidence that pulmonary vascular pathology explains the decline in lung function associated with interferon α based therapies for chronic hepatitis C virus

J Viral Hepat. 2013 Aug;20(8):592. doi: 10.1111/jvh.12105.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Albumins / adverse effects*
  • Antiviral Agents / adverse effects*
  • Female
  • Hepatitis C, Chronic / drug therapy*
  • Humans
  • Interferon-alpha / adverse effects*
  • Lung / drug effects*
  • Lung Diseases, Interstitial / chemically induced*
  • Male
  • Polyethylene Glycols / adverse effects*
  • Ribavirin / adverse effects*

Substances

  • Albumins
  • Antiviral Agents
  • Interferon-alpha
  • Polyethylene Glycols
  • Ribavirin